MaxCyte Inc (MXCT)

362.00
-10.00(-2.63%)
  • Volume:
    5,691
  • Bid/Ask:
    360.00/380.00
  • Day's Range:
    362.00 - 362.00

MXCT Overview

Prev. Close
380
Day's Range
362-362
Revenue
27.4M
Open
380
52 wk Range
330-1,235
EPS
-
Volume
5,691
Market Cap
367.57M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
86,575
P/E Ratio
-
Beta
0.65
1-Year Change
-57.3%
Shares Outstanding
101,540,052
Next Earnings Date
-
What is your sentiment on MaxCyte?
or
Vote to see community's results!

MaxCyte Inc News

MaxCyte Inc Analysis

MaxCyte Inc Company Profile

MaxCyte Inc Company Profile

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell